Effect of Arjun on cardiac function in Coronary artery disease

Phase 3

• Conditions: Health Condition 1: - Health Condition 2: I00-I99- Diseases of the circulatory system

• Registration Number: CTRI/2019/11/022034
• Lead Sponsor: Datta Meghe Institute of Medical Sciences Deemed University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1 Diagnosed patient of coronary artery disease by any of the following investigations

2 ECG (ST elevation/depression, T-wave inversion)

3 Transthoracic echocardiography(Regional wall motion abnormalities â?? wall motion score index 1.1-1.9)

4 Treadmill exercise test(TMT)

5 Stable Patients of CAD after 15 days of its onset

6 Stable Patients of CAD after one month of coronary bypass surgery, or coronary stenting.

Exclusion Criteria

1 Patients of coronary bypass surgery, or coronary stenting of the period < 1 months

2 Patients of Arrhythmia

3 Patients of severe heart failure

4 Patients with any type of serious infection.

5 Patients with Renal failure or CKD

6 Patients with Portal hypertension

7 Critically ill patient

8 Patient with Type I Diabetes mellitus or uncontrolled Type II Diabetes mellitus.

9 Patients with severe musculoskeletal disorders

10 Patients with COPD

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1 To evaluate the effect of Terminalia arjuna on Ejection fraction. <br/ ><br>2 To evaluate the effect of Terminalia arjuna on cardiac function by 6MWT (Six minute walk test). <br/ ><br>Timepoint: 1 To evaluate the effect of Terminalia arjuna on Ejection fraction. <br/ ><br>2 To evaluate the effect of Terminalia arjuna on cardiac function by 6MWT (Six minute walk test). <br/ ><br>

Secondary Outcome Measures

Name	Time	Method
1 To evaluate the effect of Terminalia arjuna in vascular inflammatory marker (hsCRP). <br/ ><br>2 To evaluate the effect of Terminalia arjuna on lipid parameters. <br/ ><br>Timepoint: 90th day